Studies have analyzed the prognosis of PCa in relation to PSA kinetics prior to treatment, and have suggested that a rapid increase in the PSA level before treatment predicted a relatively high risk of mortality from PCa7,8. The gene discussed is KLK3; the disease is posterior cortical atrophy.